Opko Health reported $394.5M in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 507.94M 13.62M
Acorda Therapeutics ACOR:US USD 82.12M 10.42M
Agios Pharmaceuticals AGIO:US USD 832.77M 47.84M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 1.4M
Amarin AMRN:US USD 686.52M 32.6M
Ardelyx ARDX:US USD 153.6M 33.73M
Arrowhead Research ARWR:US USD 575M 169.7M
Biomarin Pharmaceutical BMRN:US USD 2.75B 68.76M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Coherus Biosciences CHRS:US USD 381.23M 67.04M
Emergent Biosolutions EBS:US USD 1.21B 92.2M
Esperion Therapeutics ESPR:US USD 246.68M 15.1M
Exact Sciences EXAS:US USD 982.26M 66.25M
Exelixis EXEL:US USD 1.62B 222.86M
Halozyme Therapeutics HALO:US USD 739.01M 85.81M
Insmed INSM:US USD 1.27B 641.22M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
Ironwood Pharmaceuticals IRWD:US USD 780.63M 81.63M
Laboratory Of America LH:US USD 4.62B 253.2M
Lexicon Pharmaceuticals LXRX:US USD 140.87M 1.8M
Moderna Inc MRNA:US USD 13.43B 866M
Myriad Genetics MYGN:US USD 274.6M 77.7M
Neurocrine Biosciences NBIX:US USD 1.45B 248M
Opko Health OPK:US USD 394.5M 19.47M
Ptc Therapeutics PTCT:US USD 693.78M 176.52M
Puma Biotechnology PBYI:US USD 134.28M 11.93M
Quest Diagnostics DGX:US USD 1.9B 436M
Sarepta Therapeutics SRPT:US USD 2.56B 68.07M
Seattle Genetics SGEN:US USD 2.8B 42.91M
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M
Ultragenyx Pharmaceutical RARE:US USD 883.9M 128.77M
United Therapeutics UTHR:US USD 3.38B 323.9M
Vanda Pharmaceuticals VNDA:US USD 519.29M 12.19M